Supporting evidence
Melatonin × HbA1c
- Authoritative support
- 3
- Available studies
- 3
- Unavailable support
- 0
Available supporting studies
Study 1 · Included
Melatonin improves glycemic control in type 2 diabetes patients
Rct
- Comparison
- Patients received two tablets of 250 mg melatonin once a day for 8 weeks. · Patients received two tablets of placebo once a day for 8 weeks.
- Duration / follow-up
- 8 weeks
Relevant effect
Mean difference
1.3 · 0.02
Study 2 · Included
Melatonin shows little effect on glycemic control in type 2 diabetes
Rct
- Comparison
- Patients receiving 6 mg of melatonin nightly. · Patients receiving a placebo that contained cellulose instead of melatonin.
- Duration / follow-up
- 10 weeks
Relevant effect
Absolute change
0 · 0.912
Study 3 · Included
Melatonin shows no effect on diabetes risk markers in night workers
Rct
- Comparison
- Participants received synthetic melatonin only on days off and between shifts for 12 weeks. · Participants were instructed to take a placebo pill identical in appearance to the melatonin pill for 12 weeks.
- Duration / follow-up
- 4 weeks